Visceral Leishmaniasis: Advancements in Vaccine Development via Classical and Molecular Approaches

Visceral leishmaniasis (VL) or kala-azar, a vector-borne protozoan disease, shows endemicity in larger areas of the tropical, subtropical and the Mediterranean countries. WHO report suggested that an annual incidence of VL is nearly 200,000 to 400,000 cases, resulting in 20,000 to 30,000 deaths per...

Descripción completa

Detalles Bibliográficos
Autores principales: Joshi, Sumit, Rawat, Keerti, Yadav, Narendra Kumar, Kumar, Vikash, Siddiqi, Mohammad Imran, Dube, Anuradha
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2014
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4141159/
https://www.ncbi.nlm.nih.gov/pubmed/25202307
http://dx.doi.org/10.3389/fimmu.2014.00380

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4141159/
https://www.ncbi.nlm.nih.gov/pubmed/25202307
http://dx.doi.org/10.3389/fimmu.2014.00380

Ejemplares similares